Current Diabetes Reports

, Volume 1, Issue 1, pp 19–27 | Cite as

Type 2 diabetes in children

  • Janet H. Silverstein
  • Arlan L. Rosenbloom


The emerging epidemic of type 2 diabetes (T2DM) in young people reflects increasing rates of obesity and parallels the increasing frequency of T2DM in adults. As in adults, T2DM in children is part of the insulin resistance syndrome that includes hyperandrogenism seen as premature adrenarche and polycystic ovary syndrome, hypertension, dyslipidemia, and other atherosclerosis risk factors. Recent studies in children document risk factors for T2DM, and associated cardiovascular risk factors, including obesity, family history, diabetic gestation, and underweight or overweight for gestational age. Genetically determined insulin resistance or limited β-cell reserve has been demonstrated in high-risk individuals, including first-degree relatives of girls with premature adrenarche. This genetic background, considered advantageous in a feast-and-famine existence (the thrifty genotype), is rendered detrimental with abundant food and physical inactivity, a lifestyle demonstrated to be typical of families of children with T2DM.

The increasing incidence of T2DM in children and adolescents threatens to become a major public health problem. Risk factors for cardiovascular disease, hypertension, hyperlipidemia, and microalbuminuria are present at diagnosis of T2DM in Native American adolescents, indicating that insulin resistance has been present for some time before the diagnosis of diabetes was made. Case finding is likely to be beneficial in high-risk youths. Treatment is the same as that of adults. The only data on use of oral hypoglycemic agents in children have been with metformin. Community and governmental efforts to educate all children and their parents about the need for physical activity and dietary modification are essential to control this epidemic.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Savage PJ, Bennett PH, Senter RG, Miller M: High prevalence of diabetes in young Pima Indians. Diabetes 1979, 28:937–942.PubMedCrossRefGoogle Scholar
  2. 2.
    Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al.: Type 2 diabetes among North American children and adolescents: an epidemiological review and a public health perspective. J Pediatr 2000, 136:664–672. A thorough review of the information available from US and Canadian Indian populations, the National Health and Nutrition Examination Survey, and various clinic-based and case series data in the United States.PubMedCrossRefGoogle Scholar
  3. 3.
    Pinhas-Hamiel O, Dolan LM, Daniels SR, et al.: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128:608–615.PubMedCrossRefGoogle Scholar
  4. 4.
    Pihoker C, Scott CR, Lensing SY, et al.: Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr 1998, 37:97–102.Google Scholar
  5. 5.
    Neufeld ND, Raffal LF, Landon C, et al.: Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998, 21:80–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Deeb LC, Bauer U, Bailey BG, et al.: A five-year (1994-98) study of incidence data for diabetes in children at three university diabetes centers in Florida with special attention to type 2 diabetes. Diabetes 2000, 49(suppl 1):A177.Google Scholar
  7. 7.
    Rosenbloom AL, Joe JR, Young RS, Winter WE: The emerging epidemic of type 2 diabetes mellitus in youth. Diabetes Care 1999, 22:345–354. Summarizes the evidence for an epidemic of T2DM in children; the classification issues for non type 1 diabetes (type 2, atypical diabetes, and maturity onset diabetes of youth); pathophysiologic considerations; potential genetic markers, linkage, and defects; and the community challenge of treatment and prevention.PubMedCrossRefGoogle Scholar
  8. 8.
    Braun B, Zimmerman MB, Kretchmer N, et al.: Risk factors for diabetes and cardiovascular disease in young Australian aborigines: a 5-year follow-up study. Diabetes Care 1996, 19:472–479.PubMedCrossRefGoogle Scholar
  9. 9.
    McGrath NM, Parker GN, Dawson P: Early presentation of type 2 diabetes mellitus in young New Zealand Maori. Diabetes Res Clin Pract 1999, 43:205–209.PubMedCrossRefGoogle Scholar
  10. 10.
    Lev-Ran A: Thrifty genotype: how applicable is it to obesity and type 2 diabetes? Diabetes Rev 1999, 7:1–22. A thoughtful, erudite, and well-referenced discussion of the apparent multifactorial genetic background for obesity and T2DM. It considers mutation accumulation in more or less isolated communities that in the past benefited from these characteristics.Google Scholar
  11. 11.
    Phipps K, Barker DJP: Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993, 36:225–228.PubMedCrossRefGoogle Scholar
  12. 12.
    Philips DIW, Barker DJP, Hales CN, et al.: Thinness at birth and insulin resistance in adult life. Diabetologia 1994, 37:150–154.CrossRefGoogle Scholar
  13. 13.
    Lithell HO, McKeigue PM, Gerglund L, et al.: Relation at birth to non-insulin-dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996, 312:406–410.PubMedGoogle Scholar
  14. 14.
    Curhan GC, Willett WC, Rimm EB, et al.: Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996, 94:3246–3250.PubMedGoogle Scholar
  15. 15.
    Ravelli AC, van der Meulen JH, Michels RP, et al.: Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998, 351:173–177.PubMedCrossRefGoogle Scholar
  16. 16.
    Levitt NS, Lambert EV, Woods D, et al.: Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young South African adults: early programming of cortisol axis. J Clin Endocrinol Metab 2000, 85:4611–4618. Documents cortisol axis activation as an early feature that links low birth weight with adult cardiovascular and metabolic disease independently of obesity. Clark et al. (Clin Endocrinol 1996, 45:721–726) initially demonstrated that children of low weight for gestational age had increased adrenal steroid excretion. Phillips et al. (Hypertension 2000, 35:1301–1306) confirmed the association of low birth weight and elevated plasma cortisol in adulthood in young adult, middle-aged, and elderly populations from the United Kingdom and Australia.PubMedCrossRefGoogle Scholar
  17. 17.
    Dabelea D, Pettitt DJ, Hanson RL, et al.: Birthweight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 1999, 22:944–950.PubMedCrossRefGoogle Scholar
  18. 18.
    Bavdekar A, Yajnik CS, Fall CHD, et al.: Insulin resistance syndrome in 8-year old Indian children: small at birth, big at 8 years, or both? Diabetes 1999, 48:2422–2429. The first study of insulin resistance syndrome variables and risk factors in children in relation to birth weight and childhood weight. The most adverse risk profiles were in children who were born small but who became relatively fat and tall at age 8 years. This is similar to results from the accumulating studies in adults in the United Kingdom [11,12], Sweden [13], the United States [14], and Finland (Eriksson et al., BMJ 1999, 318:427–431).PubMedCrossRefGoogle Scholar
  19. 19.
    Caprio S, Tamborlane WV: Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999, 28:731–747. A concise but thorough review of the altered metabolism associated with obesity particularly abdominal including insulin resistance, β-cell function, the role of leptin, the GH IGF-I axis, and cardiovascular risk factors.PubMedCrossRefGoogle Scholar
  20. 20.
    Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999, 84:165–169.PubMedCrossRefGoogle Scholar
  21. 21.
    Lewy V, Danadian K, Arslanian SA: Early metabolic abnormalities in adolescents with polycystic ovarian syndrome (PCOS). Pediatr Res 1999, 45:93A.CrossRefGoogle Scholar
  22. 22.
    Lewy V, Danadian K, Arslanian SA: Roles of insulin resistance & β-cell dysfunction in the pathogenesis of glucose intolerance in adolescents with polycystic ovary syndrome. Diabetes 1999, 48:A292.CrossRefGoogle Scholar
  23. 23.
    Banerjee S, Raghavan S, Wasserman EJ, et al.: Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998, 102:E36.PubMedCrossRefGoogle Scholar
  24. 24.
    Vuguin P, Linder B, Rosenfeld RG, et al.: The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGFbinding protein-1 and-3 in the hyperandrogenism of African American and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab 1999, 84:2037–2042. Demonstrated that insulin and the GH IGF-I axis may have a role in the hyperandrogenism of premature adrenarche as in PCOS, which suggested that in some girls with premature adrenarche hyperandrogenism may be the first indication of insulin resistance.PubMedCrossRefGoogle Scholar
  25. 25.
    Ibaez L, Potau N, Marcos MV, deZegher F: Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999, 84:4739–4741. Demonstrated the link between small size of birth and premature adrenarche in addition to the recognized association of low birth weight with hyperinsulinism/insulin resistance.CrossRefGoogle Scholar
  26. 26.
    Silverman BL, Metzger BE, Cho NH, Loeb CA: Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabetes Care 1995, 18:611–617.PubMedCrossRefGoogle Scholar
  27. 27.
    Pettitt DJ, Aleck KA, Baird HR, et al.: Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes 1988, 37:622–628.PubMedCrossRefGoogle Scholar
  28. 28.
    Svec F, Nastasi K, Hilton C, et al.: Black-white contrasts and insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes 1992, 41:313–317.PubMedCrossRefGoogle Scholar
  29. 29.
    Jiang X, Srinivasan SR, Radhakrishnamurthy B, et al.: Racial (black-white) differences in insulin secretion and clearance in adolescents: the Bogalusa heart study. Pediatrics 1996, 97:357–360.PubMedGoogle Scholar
  30. 30.
    Arslanian S: Insulin secretion and sensitivity in healthy African-American versus American-white children. Clin Pediatr 1998, 37:81–88.Google Scholar
  31. 31.
    Danadian K, Balasekaran G, Lewy V, et al.: Insulin sensitivity in African-American children with and without a family history of type 2 diabetes. Diabetes Care 1999, 22:1325–1329. Numerous studies have been performed in adults with a family history of T2DM. However, this is the first study to demonstrate insulin resistance, compared with control subjects, in children as young as the second decade of life with such a history. The study used sophisticated techniques for measuring sensitivity (hyperinsulinemic-euglycemic clamp) and controlled for body composition (dual-energy x-ray absorptiometry and CT) and maximal oxygen consumption.PubMedCrossRefGoogle Scholar
  32. 32.
    Dabelea D, Pettitt DJ, Jones KL, Arslanian SA: Type 2 diabetes mellitus in minority children and adolescents: an emerging problem. Endocrinol Metab Clin North Am 1999, 28:709–729. This is an extensive review of the experience of childhood T2DM in African American, Mexican American, and Native American populations.PubMedCrossRefGoogle Scholar
  33. 33.
    Ibaez L, Castell C, Tresserras R, Potau N: Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche. Clin Endocrinol 1999, 51:395–401. A markedly increased risk of IGT and T2DM was found among firstdegree relatives of girls with precocious adrenarche, usually accompanied by an unfavorable lipid profile and commonly with hyperandrogenism and gestational diabetes. This emphasizes again the relationship between premature adrenarche and insulin resistance syndrome.CrossRefGoogle Scholar
  34. 34.
    Pinhas-Hamiel O, Standiford D, Hamiel D, et al.: The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999, 153:1063–1067. Emphasizes the importance of the familial lifestyle as the environmental stress necessary for expression of T2DM at any age. Family members were obese, inactive, had a high-fat and low-fiber intake, and those with diabetes were in poor control.PubMedGoogle Scholar
  35. 35.
    Kirn TF: Actively screen for type 2 diabetes in those at risk. Pediatr News 2000, 34:1,7.Google Scholar
  36. 36.
    Fagot Campagna A, Knowler WC, Pettitt DJ: Type 2 diabetes in Pima Indian children: cardiovascular risk factors at diagnosis and 10 years later. Diabetes 1988, 47(suppl 1):A155.Google Scholar
  37. 37.
    American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 2000, 23:381–389. This consensus statement provides an excellent overview of the state of knowledge of T2DM in children, with recommendations for case finding, current methods of treatment, and further studies.CrossRefGoogle Scholar
  38. 38.
    Rosenbloom AL: Type 2 diabetes in children. Diagn Endocrinol Immunol Metab 2000, 18:139–160.Google Scholar
  39. 39.
    Dean H: Treatment of type 2 diabetes in youth: an argument for randomized controlled studies. Pediatr Child Health 1999, 4:265–269.Google Scholar
  40. 40.
    UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837–853. Intensive blood glucose control resulted in reduced risk of microvascular disease in patients with T2DM. The results were similar to those found in the Diabetes Control and Complications Trial for type 1 diabetes. Only 3% of patients were able to maintain target blood glucose control with conventional means of diet and exercise alone, making a case for earlier aggressive treatment with pharmacologic agents.CrossRefGoogle Scholar
  41. 41.
    Hamley A, Harris S, Gittelson J, et al.: Pediatric obesity in a native Canadian community with epidemic levels of type 2 diabetes mellitus [abstract]. Diabetes 1999, 48(suppl 1):A169.Google Scholar
  42. 42.
    Jones K, Arslanian S, McVie R, et al., Metformin Pediatric Study Group: Metformin improves glycemic control in children with type 2 diabetes [abstract]. Diabetes 2000, 49(suppl 1):A75. The first report of use of an oral hypoglycemic agent in children. It suggests that adolescents respond similarly to adults to these agents, with improvement in HbA1C and fasting blood glucose levels.Google Scholar
  43. 43.
    Silverstein JH, Rosenbloom AL: Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2000, 13(suppl 5):1–7.Google Scholar
  44. 44.
    Haffner SM, Alexander CM, Cook TJ, et al.: Reduced coronary events in Simvastatin treated patients with coronary heart disease and diabetes or impaired fasting glucose levels. Arch Intern Med 1999, 59:2661–2667.CrossRefGoogle Scholar
  45. 45.
    Berenson GS, Srinivasan SR, Bao W, et al.: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998, 338:1650–1656.PubMedCrossRefGoogle Scholar
  46. 46.
    Cull CA, Mehta Z, Stratton IM, et al.: Association of lipid levels over time with clinical outcomes in patients with type 2 diabetes in the UKPDS [abstract]. Diabetes 2000, 49(suppl 1):A267.Google Scholar
  47. 47.
    Law RE, Goetz ES, Pxi XP, et al.: Expression and function of PPAR gamma in rat and human vascular smooth muscle cells. Circulation 2000, 101:1311–1318.PubMedGoogle Scholar
  48. 48.
    UK Perspective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703–713. Showed that blood pressure control is important in decreasing the risk of macrovascular disease in T2DM. Blood pressure control decreased risk of microvascular disease at least as well as blood glucose control, emphasizing the need to aggressively treat blood pressure as well as blood glucose levels.Google Scholar
  49. 49.
    Van Dam RM, Schuit AJ, Feskens EJM, et al.: Physical activity and glucose tolerance in elderly men: Zutphen Elderly Study [abstract 442]. Program and Abstracts of the 36th Annual Meeting of the European Association for the Study of Diabetes. September 17–21, 2000. Jerusalem, Israel.Google Scholar
  50. 50.
    Ilanne-Parikka P, Salminen V, Lindstrom J, et al.: The effects of intensive diet and exercise programs in subjects with impaired glucose tolerance (IGT) [abstract 440]. Programs and Abstracts of the 36th Annual Meeting of the European Association for the Study of Diabetes. September 17–21, 2000. Jerusalem, Israel.Google Scholar
  51. 51.
    Harrell JS, Gansky SA, McMurray RG, et al.: School-based interventions improve heart health in children with multiple cardiovascular disease risk factors. Pediatrics 1998, 102:371–380.PubMedCrossRefGoogle Scholar
  52. 52.
    Cook VV, Hurley JS: Prevention of type 2 diabetes in childhood. Clin Pediatr 1998, 37:123–129.Google Scholar
  53. 53.
    Bernstein G: Type 2 diabetes in children and adolescents. Available at: diabetology/index.html09/2000. Accessed September 2000.Google Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Janet H. Silverstein
    • 1
  • Arlan L. Rosenbloom
    • 1
  1. 1.Division of Endocrinology, Department of PediatricsUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations